Utility of RNA Sequencing and Immunohistochemistry for NTRK Fusion in Thyroid Carcinoma. Toda S, Kasajima R, Okubo Y, Saito N, et al. Anticancer Res 2026;46:4923-4933.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Toda S, Kasajima R, Okubo Y, Saito N, et al. Utility of RNA Sequencing and Immunohistochemistry for NTRK Fusion in Thyroid Carcinoma. Anticancer Res 2026;46:4923-4933.
PMID: 42674723